Excelsior Biopharma Inc (6496) Stock Price & Analysis
6496 Stock Chart & Stats
- Day’s Range
- TWD 22.10 - TWD 23.10
- 52-Week Range
- TWD 22.10 - TWD 30.55
- Previous Close
- TWD 23.40
- Volume
- N/A
- Average Volume (3M)
- 27.81K
- Market Cap
- TWD 1.09B
- Enterprise Value
- TWD 1.64B
- Total Cash (Recent Filing)
- TWD 141.10M
- Total Debt (Recent Filing)
- TWD 524.98M
- Price to Earnings (P/E)
- ―
- Beta
- 0.13
- Next Earnings
- Feb 19, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 13, 2021
- Dividend Yield
- N/A
6496 FAQ
What was Excelsior Biopharma Inc’s price range in the past 12 months?
What is Excelsior Biopharma Inc’s market cap?
When is Excelsior Biopharma Inc’s upcoming earnings report date?
How were Excelsior Biopharma Inc’s earnings last quarter?
Is Excelsior Biopharma Inc overvalued?
Does Excelsior Biopharma Inc pay dividends?
What is Excelsior Biopharma Inc’s EPS estimate?
How many shares outstanding does Excelsior Biopharma Inc have?
What happened to Excelsior Biopharma Inc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Excelsior Biopharma Inc?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Excelsior Biopharma Inc
Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Joseph Chen
- Employees
- 15
- Website
- www.excelsiorgroup.com.tw
- Address
- No. 508, Zhongxiao E. Rd., Taipei, TPE, 11561, TW
Excelsior Biopharma Inc (6496) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 4 | 14 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 0 | 0 | 12 |
